Related Experiment Video

Updated: May 16, 2026

Combination of High Ligation and Intraoperative Embolization Using Polidocanol for Treatment of Varicoceles
03:06

Combination of High Ligation and Intraoperative Embolization Using Polidocanol for Treatment of Varicoceles

Published on: December 22, 2023

Cholesterol atheroembolism and combined treatment with steroids and iloprost

Ángel M Sevillano-Prieto1, Eduardo Hernández-Martínez, Jara Caro-Espada

  • 1Servicio de Nefrología. Hospital Universitario 12 de Octubre. Madrid, Spain. sevillano.am@gmail.com

Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|November 22, 2012
PubMed

Insights

Cholesterol atheroembolism (CAE) is a serious condition with increasing cases. A combined therapy of steroids and prostaglandin analogues showed positive results in a patient with multi-organ involvement.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Dermatology

Background:

  • Cholesterol atheroembolism (CAE) is a systemic vascular disease with rising incidence.
  • CAE is associated with significant morbidity and mortality.
  • Optimal treatment strategies for CAE remain debated due to a lack of consensus.

Observation:

  • A case of cholesterol atheroembolism involving the skin, bowel, and kidneys is presented.
  • The patient exhibited signs of systemic organ compromise.

Findings:

  • The patient demonstrated a favorable response to a combined therapeutic regimen.
  • This regimen included the administration of steroids and prostaglandin analogues.

Implications:

  • The combined therapy of steroids and prostaglandin analogues may be a viable option for managing CAE.
  • This approach could be particularly beneficial in cases with significant organic failure.
  • Further conclusive studies are warranted to validate these findings.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...